Ignite Creation Date:
2025-12-25 @ 2:08 AM
Ignite Modification Date:
2026-05-09 @ 3:30 AM
Study NCT ID:
NCT00022360
Status:
COMPLETED
Last Update Posted:
2013-06-18
First Post:
2001-08-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Taurolidine in Treating Patients With Recurrent or Progressive Glioma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MSKCC-01057
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |